T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Agilysys
AGYS
$3.25B
| $48.1M | 0.01% |
404,391
+1,868
| +0.5% | +$225K |
|
827
Lennox International
LII
$14.5B
| $47.7M | 0.01% |
98,160
-36,019
| -27% | -$18M |
|
828
Royalty Pharma
RPRX
$26.1B
| $47.7M | 0.01% |
1,233,421
+202,637
| +20% | +$7.73M |
|
829
American Healthcare REIT
AHR
$10.3B
| $47.2M | 0.01% |
1,001,938
+2,820
| +0.3% | +$131K |
|
830
NewMarket
NEU
$8.72B
| $46.4M | 0.01% |
67,487
+1,295
| +2% | +$989K |
|
831
Nexstar Media Group
NXST
$5.81B
| $46.1M | 0.01% |
227,081
+26,577
| +13% | +$5.19M |
|
832
M&T Bank
MTB
$36.6B
| $46M | 0.01% |
228,406
+2,720
| +1% | +$520K |
|
833
EXL Service
EXLS
$5.36B
| $45.7M | ﹤0.01% |
1,077,456
-809,701
| -43% | -$33.1M |
|
834
Alarm.com
ALRM
$2.74B
| $45.7M | ﹤0.01% |
895,619
+53,775
| +6% | +$2.74M |
|
835
Hewlett Packard
HPE
$79.2B
| $45.6M | ﹤0.01% |
1,900,164
-17,239
| -0.9% | -$406K |
|
836
Dyne Therapeutics
DYN
$4.85B
| $45.5M | ﹤0.01% |
2,323,789
+925,702
| +66% | +$17.5M |
|
837
Warby Parker
WRBY
$3.2B
| $45.3M | ﹤0.01% |
2,078,778
+865,345
| +71% | +$18.8M |
|
838
Joby Aviation
JOBY
$8.17B
| $44.7M | ﹤0.01% |
3,384,180
+1,512,094
| +81% | +$23.2M |
|
839
TD Synnex
SNX
$20.4B
| $44.5M | ﹤0.01% |
295,931
+2,675
| +0.9% | +$410K |
|
840
VeriSign
VRSN
$26B
| $43.7M | ﹤0.01% |
179,716
+28,648
| +19% | +$7.2M |
|
841
Array Technologies
ARRY
$796M
| $43.6M | ﹤0.01% |
4,730,258
+179,276
| +4% | +$1.54M |
|
842
Badger Meter
BMI
$3.78B
| $43.5M | ﹤0.01% |
249,620
+3,629
| +1% | +$653K |
|
843
Duolingo
DUOL
$6.74B
| $43.4M | ﹤0.01% |
247,130
-280,375
| -53% | -$66.1M |
|
844
Churchill Downs
CHDN
$6.2B
| $43.3M | ﹤0.01% |
380,817
+33,009
| +9% | +$3.42M |
|
845
Northern Trust
NTRS
$34.8B
| $43.2M | ﹤0.01% |
316,434
-79,401
| -20% | -$10.4M |
|
846
Simpson Manufacturing
SSD
$8B
| $43.2M | ﹤0.01% |
267,445
-125,937
| -32% | -$21.3M |
|
847
Twilio
TWLO
$38.3B
| $43.2M | ﹤0.01% |
303,401
+9,377
| +3% | +$1.16M |
|
|
CSW
848
CSW Industrials
CSW
$5.59B
| $43.1M | ﹤0.01% |
146,885
+1,552
| +1% | +$414K |
|
849
Williams-Sonoma
WSM
$28.5B
| $42.9M | ﹤0.01% |
240,114
-579
| -0.2% | -$108K |
|
850
Occidental Petroleum
OXY
$57.7B
| $42.8M | ﹤0.01% |
1,041,207
+10,773
| +1% | +$450K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.